INHIBITION OF ANGIOTENSIN-I CONVERTING ENZYME BY FLAVANOLIC COMPOUNDS - INVITRO AND INVIVO STUDIES

被引:21
作者
MEUNIER, MT
VILLIE, F
JONADET, M
BASTIDE, J
BASTIDE, P
机构
[1] FAC PHARM CLERMONT FERRAND, CHIM BIOL & PHARMACODYNAM LAB, 28 PL HENRI DUNANT, F-63001 CLERMONT FERRAND, FRANCE
[2] FAC PHARM CLERMONT FERRAND, CNRS, F-63001 CLERMONT FERRAND, FRANCE
关键词
D O I
10.1055/s-2006-962606
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The procyanidolic oligomers coming from Vitis vinifera L. (two fractions) and Cupressus sempervirens L. (three fractions), and the monomers, (+)-catechin, (-)-epicatechin were tested for their effects on angiotensin I converting enzyme (ACE) activity. The oligomers are the most active (dose I50 of 0.08 mg/ml for the fraction A of Vitis, the most active substance). Monomers have little activity. In vivo, the vasopressive response to Ang I is inhibited by approximately 20% to 40% in the rabbit after administration of procyanidolic oligomers (5 mg/kg i.v.). Ang II also is inhibited which suggests another action, perhaps due to the forming of compounds between Ang I and II and the oligomers.
引用
收藏
页码:12 / 15
页数:4
相关论文
共 13 条
[1]   INHIBITION O HOMOGENEOUS ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG BY SYNTHETIC VENOM PEPTIDES OF BOTHROPS-JARARACA [J].
CHEUNG, HS ;
CUSHMAN, DW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 293 (02) :451-463
[2]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[3]  
FUNAE Y, 1980, BIOCHEM PHARMACOL, V29, P1543
[4]  
JONADET M, 1984, J PHARMACOL-PARIS, V15, P546
[5]  
JONADET M, 1984, ANN PHARM FR, V42, P161
[6]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[7]  
Masquelier J., 1981, Acta Therapeutica, V7, P101
[8]  
MEUNIER MT, 1982, J PHARMACOL-PARIS, V13, P483
[9]  
MICHAUD J, 1973, PROD PROBL PHARM, V28, P499
[10]  
PIERI E, 1983, LYON PHARM, V34, P187